Cannon Global Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,800	Closed	-$681K	–	42
2024 Q1	$681K	Buy	7,800 +800	+11%	+$69.9K	1.83%	12
2023 Q4	$675K	Buy	+7,000	New	+$675K	5.07%	5
2023 Q3	–	Sell	-5,000	Closed	-$433K	–	30
2023 Q2	$433K	Buy	+5,000	New	+$433K	2.25%	17